Feature
Feature
States move to curb insurers’ prior authorization requirements as federal reforms lag
Doctors and patients in several states would get some relief from burdensome prior authorization requirements if reform legislation becomes law....
Feature
The weird world of hydrogels: How they’ll change health care
“As people develop new hydrogels that more closely match the tissues in our body, we’ll be able to treat a whole host of ailments we couldn’t...
Livin' on the MDedge
People still want their medical intelligence in human form
Plus: Finding humor in the temporal lobe and comparing reproductive inequality in mammals.
Livin' on the MDedge
The antimicrobial peptide that even Pharma can love
Faster wound healing comes in waves, and a cancer drug that eats bugs.
Livin' on the MDedge
Boys may carry the weight, or overweight, of adults’ infertility
Plus: The promise of fecal beads and the air of sleep-dieting.
Livin' on the MDedge
Medical-level empathy? Yup, ChatGPT can fake that
Plus: Fishy sperm, an even more fishy sperm donor, and aviation-related sleep deserts.
Feature
Researchers seek to understand post-COVID autoimmune disease risk
Three large studies link past SARS-CoV-2 infection to new-onset autoimmune disease, but it is not yet clear what drives this relationship.
Latest News
Personalizing treatment plans for older patients with T2D
There is an increased risk for health-related comorbidities and complications from diabetes treatment such as hypoglycemia, in older adults.
Feature
Should youth with type 1 diabetes use closed-loop systems?
Several studies show the adolescents who were disengaged from their diabetes management do better on closed-loop systems.
Latest News
Obesity drugs overpriced, change needed to tackle issue
Millions of lives have been saved by treating infectious diseases at low cost in poor countries, and we need to repeat this success story with...
Feature
Tirzepatide scores win in second obesity trial, SURMOUNT-2
Tirzepatide (Mounjaro) met its primary endpoints, compared with placebo, in the SURMOUNT-2 trial, designed to test weight-loss efficacy, in top-...